FdaApplication
NDA 203568
Identifiers
- fda_app_no: NDA203568
Properties
| Property | Value |
|---|---|
| applicant_name | KASTLE THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2013-01-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KYNAMRO | MIPOMERSEN SODIUM | 200MG/ML (200MG/ML) | SOLUTION;SUBCUTANEOUS |
1 product